Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02447302
What this trial is testing

Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Arena Pharmaceuticals 156
Large-scale testing (Phase 3)Study completedNCT02665845
What this trial is testing

Combination Corticosteroids+5-aminosalicylic Acids Compared to Corticosteroids Alone (for Ulcerative Colitis).

Who this might be right for
Ulcerative Colitis
Centre Hospitalier Universitaire de Saint Etienne 160
Post-approval studies (Phase 4)Study completedNCT06626165
What this trial is testing

Association Between Effectiveness of Mirikizumab and UC Patients With High Neutrophilic Infiltration in Epithelium of the Colonic Mucosa

Who this might be right for
Ulcerative Colitis
Showa Inan General Hospital 100
Early research (Phase 1)Not Yet RecruitingNCT07747467
What this trial is testing

Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
GlaxoSmithKline 16
Testing effectiveness (Phase 2)Ended earlyNCT03599622
What this trial is testing

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Who this might be right for
Granulomatous ColitisCrohn's DiseaseCrohn's Enteritis+1 more
Bristol-Myers Squibb 239
Not applicableStudy completedNCT05394805
What this trial is testing

Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie 156
Not applicableStudy completedNCT00524537
What this trial is testing

A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
AbbVie (prior sponsor, Abbott) 5,025
Large-scale testing (Phase 3)Active Not RecruitingNCT03596645
What this trial is testing

Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 84
Not applicableEnded earlyNCT07653750
What this trial is testing

Study on Variation of Serum and Fecal Biomarkers After Treatment to Predict Mucosal Healing in Patients With Ulcerative Colitis

Who this might be right for
Moderate to Severe Ulcerative Colitis
University Hospital, Clermont-Ferrand 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT06867094
What this trial is testing

Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

Who this might be right for
Colitis Ulcerative
Sanofi 204
Large-scale testing (Phase 3)Study completedNCT02394028
What this trial is testing

Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Hoffmann-La Roche 1,035
Not applicableLooking for participantsNCT06023030
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan

Who this might be right for
Crohn's Disease
AbbVie 240
Testing effectiveness (Phase 2)Study completedNCT03662542
What this trial is testing

Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 214
Not applicableLooking for participantsNCT07726888
What this trial is testing

Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (Disorder)Guselkumab
Second Affiliated Hospital of Wenzhou Medical University 97
Large-scale testing (Phase 3)WithdrawnNCT03905109
What this trial is testing

Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease Patients

Who this might be right for
Crohn Disease
Abivax S.A.
Large-scale testing (Phase 3)Study completedNCT01863771
What this trial is testing

A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.

Who this might be right for
Colitis, Ulcerative
Janssen Pharmaceutical K.K. 144
Testing effectiveness (Phase 2)Study completedNCT00055367
What this trial is testing

Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease

Who this might be right for
Crohn's Disease
Biogen 30
Not applicableNot Yet RecruitingNCT07062185
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ENC1018 Capsules in Patients With Moderate-to-severe Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis (UC)
Tang-Du Hospital 10
Early research (Phase 1)UnknownNCT01874015
What this trial is testing

Transplantation of Bone Marrow Mesenchymal Stem Cell in Crohn's Disease

Who this might be right for
Crohn's Disease
Royan Institute 10
Large-scale testing (Phase 3)Ended earlyNCT03627091
What this trial is testing

Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)

Who this might be right for
Crohn's Disease
Shire 40
Next Page